ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PFZ Pfizer

18.78
0.00 (0.00%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Pfizer LSE:PFZ London Ordinary Share COM STK USD0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.78 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

T.Rowe Price Associates Form 8.3 - [PFIZER INC] (3486G)

19/11/2015 3:13pm

UK Regulatory


Pfizer (LSE:PFZ)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Pfizer Charts.

TIDMPFZ

RNS Number : 3486G

T.Rowe Price Associates

19 November 2015

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES

REPRESENTING 1% OR MORE

   1.         KEY INFORMATION 
 
 Name of person dealing                  T. ROWE PRICE ASSOCIATES, INC. 
  (Note 1) 
--------------------------------------  ------------------------------- 
 Company dealt in                        PFIZER INC 
--------------------------------------  ------------------------------- 
            Class of relevant security   ISIN: US7170811035 
             to which the dealings 
             being disclosed relate 
             (Note 2) 
--------------------------------------  ------------------------------- 
            Date of dealing                         18 November 2015 
--------------------------------------  ------------------------------- 
 
   2.         INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                          Long            Short 
---------------------------------  ------------------  ----------- 
                                    Number (%)          Number (%) 
---------------------------------  ------------------  ----------- 
      (1) Relevant securities       108,956,991 1.76% 
---------------------------------  ------------------  ----------- 
      (2) Derivatives (other 
       than options) 
---------------------------------  ------------------  ----------- 
      (3) Options and agreements 
       to purchase/sell 
---------------------------------  ------------------  ----------- 
 Total                              108,956,991 1.76% 
---------------------------------  ------------------  ----------- 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
 Class of relevant security:          Long        Short 
--------------------------------  -----------  ----------- 
                                   Number (%)   Number (%) 
--------------------------------  -----------  ----------- 
      (1) Relevant securities 
--------------------------------  -----------  ----------- 
      (2) Derivatives (other 
       than options) 
--------------------------------  -----------  ----------- 
      (3) Options and agreements 
       to purchase/sell 
--------------------------------  -----------  ----------- 
 Total 
--------------------------------  -----------  ----------- 
 
   3.         DEALINGS (Note 4) 
   (a)        Purchases and sales 
 
 Purchase/sale   Number of securities   Price per unit (Note 
                                         5) 
--------------  ---------------------  --------------------- 
 Purchases       1,000                  33.051 USD 
                  2,900                  33.098 USD 
                  2,200                  33.259 USD 
                  210                    33.268 USD 
--------------  ---------------------  --------------------- 
 
   (b)        Derivatives transactions (other than options) 
 
 Product name,   Long/short   Number of securities   Price per unit 
  e.g. CFD        (Note 6)     (Note 7)               (Note 5) 
--------------  -----------  ---------------------  --------------- 
 
 
   (c)        Options transactions in respect of existing securities 
   (i)         Writing, selling, purchasing or varying 
 
 Product name,   Writing,       Number of        Exercise   Type,             Expiry   Option 
  e.g. call       selling,       securities       price      e.g. American,    date     money 
  option          purchasing,    to which                    European                   paid/received 
                  varying        the option                  etc.                       per unit 
                  etc.           relates (Note                                          (Note 5) 
                                 7) 
--------------  -------------  ---------------  ---------  ----------------  -------  --------------- 
 
 
   (ii)        Exercising 
 
 Product name, e.g.   Number of securities   Exercise price per 
  call option                                 unit (Note 5) 
-------------------  ---------------------  ------------------- 
 
 
   (d)        Other dealings (including new securities) (Note 4) 
 
 Nature of transaction   Details   Price per unit (if 
  (Note 8)                          applicable) (Note 
                                    5) 
----------------------  --------  ------------------- 
 
 
   4.         OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding 
  between the person disclosing and any other person relating 
  to the voting rights of any relevant securities under 
  any option referred to on this form or relating to the 
  voting rights or future acquisition or disposal of any 
  relevant securities to which any derivative referred 
  to on this form is referenced. If none, this should 
  be stated. 
------------------------------------------------------------- 
 
   None 
------------------------------------------------------------- 
 
   Is a Supplemental Form 8 attached? (Note 9)                                                 NO 
 
            Date of disclosure                  19 November 2015 
---------------------------------------------  ----------------- 
            Contact name                        Gary Greb 
---------------------------------------------  ----------------- 
            Telephone number                    001 410 345 2527 
---------------------------------------------  ----------------- 
 If a connected EFM, name of offeree/offeror 
  with which connected 
---------------------------------------------  ----------------- 
            If a connected EFM, state nature 
             of connection (Note 10) 
---------------------------------------------  ----------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETUKAVRVRAAAAA

(END) Dow Jones Newswires

November 19, 2015 10:13 ET (15:13 GMT)

1 Year Pfizer Chart

1 Year Pfizer Chart

1 Month Pfizer Chart

1 Month Pfizer Chart

Your Recent History

Delayed Upgrade Clock